Assure is authorized to list on the NASDAQ Capital Market under the new symbol “IONM”



DENVER, September 24, 2021 (GLOBE NEWSWIRE) – Assure Holdings Corp. (the “Society” Where “To assure“) (TSXV: IOM; OTCQB: ARHH; OTCQB: ARHHD*), an intraoperative neuromonitoring service provider (“IONM“), announced that its common shares have been approved for listing on the NASDAQ Capital Market (“NASDAQ“). Trading on NASDAQ is scheduled to begin September 29, 2021, under the symbol “IONM”.

The Company’s common shares will continue to trade on the OTCQB® Venture Market, operated by OTC Markets Group, until trading begins on the NASDAQ. The Company will also maintain its listing on the TSX Venture Exchange under the symbol “IOM”.

John A. Farlinger, Executive Chairman and CEO of Assure, said, “Our NASDAQ listing is a significant milestone for Assure. We believe that a NASDAQ listing increases Assure’s visibility in the industry. In addition, the listing is expected to provide increased liquidity to our investors, improve our access to capital and increase the value of our common shares for future M&A transactions.

Farlinger continued, “This is an exciting time for Assure. While continuing to provide exceptional clinical care, we have made progress in expanding our operational and geographic platform, increasing our procedural volume, and developing robust systems to manage our revenue and collection cycle. “

* The Company’s stock symbol OTCQB has been designated with a “D” (ARHHD) for 20 trading days to indicate a reverse stock split completed on September 8, 2021.

About Assure Holdings
Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a suite of turnkey services supporting intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, manages 100% of the planning and configuration of intraoperative neuromonitoring, and invoices all technical services provided. Assure Neuromonitoring is recognized as providing the highest standard of patient care in the industry and has won the Joint Commission Gold Seal of Approval®. For more information, visit the Company’s website at www.assureneuromonitoring.com.

Forward-looking statements
This press release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to: the performance by the Company of its primary business objectives; the expected date of listing of the Company on the NASDAQ Capital Market; the benefits of listing Assure’s common shares on the NASDAQ Capital Market; the increased visibility and notoriety created by a listing on a national stock exchange; the potential increase in liquidity; improving the profile of future M&A transactions and other estimates and expected results. Forward-looking statements can generally be identified by the use of the words “expected”, “believes”, “increase”, “expects”, “potential” or “continue” and variations or similar expressions. These statements are based on management’s current expectations, beliefs and projections and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in forward-looking statements. These risks and uncertainties include, but are not limited to: uncertainty surrounding the spread of COVID-19, increase in COVID-19 cases, restrictions on elective surgeries due to hospital capacity and staff shortages , government mandates due to COVID-19 and other adverse effects. the consequences of the pandemic; the Company’s ability to successfully develop or implement its acquisition strategies; the Company’s management of revenue and collection cycles; ability to collect overdue accounts receivable; the Company may not be able to execute these key business objectives; uncertainties related to market conditions; the impact of legislative changes, healthcare reform, economic activity in general, could have on the operations and financial results of the Company; the operations envisaged by the Company within the framework of its operations on the capital markets, opportunities for expansion or growth; and the risks and uncertainties discussed in our most recent annual and quarterly reports filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com and with the United States Securities and Exchange Commission and available at www.sec. govt. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Assure does not intend and assumes no obligation to update forward-looking statements to reflect, in particular, new information or future events.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact

Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-287-3093
[email protected]


Previous High Peak Royalties Ltd Shuts Down Before Completion of Capital Raising
Next Should I trigger capital gains tax now - or wait until I'm gone?

No Comment

Leave a reply

Your email address will not be published.